Michael McCann

Mike is the chief commercial officer, responsible for the development and execution of the commercial launch strategy for the PDS-2TM System. He has over 25 years of biopharma commercial experience across sales, marketing, commercial operations, multiple product launches including major cardiovascular and rare disease products.

Most recently he was Vice President of Sales and Sales Operations at DBV Technologies. Prior to joining DBV Technologies, he was Head, U.S. Sales & Marketing at Noden Pharma with responsibility for building the entire US commercial organization. Prior to Noden Pharma, he was Head, U.S. Cardiovascular – Rare Diseases at Sanofi Genzyme. Prior to Sanofi Genzyme, he was Vice President, Sales & Operations at Shionogi Inc. Prior to Shionogi he held various commercial leadership positions of increasing responsibility at Schering-Plough (now Merck) including Area Vice President, Sales, and Senior Director, Cardiovascular Marketing U.S./Latin America.

Mike received his B.B.A. in Marketing from Marshall University.